Shell Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53K | Sell |
|
|||||
|
2025
Q1 | $78K | Sell |
|
|||||
|
2024
Q4 | $94K | Sell |
|
|||||
|
2024
Q3 | $125K | Buy |
|
|||||
|
2024
Q1 | $98K | Sell |
|
|||||
|
2023
Q4 | $126K | Sell |
|
|||||
|
2023
Q3 | $122K | Sell |
|
|||||
|
2023
Q2 | $160K | Sell |
|
|||||
|
2023
Q1 | $140K | Sell |
|
|||||
|
2022
Q4 | $163K | Sell |
|
|||||
|
2022
Q3 | $175K | Sell |
|
|||||
|
2022
Q2 | $318K | Buy |
|
|||||
|
2022
Q1 | $386K | Sell |
|
|||||
|
2021
Q4 | $514K | Buy |
|
|||||
|
2021
Q3 | $549K | Sell |
|
|||||
|
2021
Q2 | $605K | Buy |
|
|||||
|
2021
Q1 | $684K | Buy |
|
|||||
|
2020
Q4 | $577K | Sell |
|
|||||
|
2020
Q3 | $398K | Hold |
|
|||||
|
2020
Q2 | $379K | Sell |
|
|||||
|
2020
Q1 | $219K | Sell |
|
|||||
|
2019
Q4 | $214K | Sell |
|
|||||
|
2019
Q3 | $220K | Sell |
|
|||||
|
2019
Q2 | $329K | Sell |
|
|||||
|
2019
Q1 | $368K | Hold |
|
|||||
|
2018
Q4 | $230K | Sell |
|
|||||
|
2018
Q3 | $435K | Buy |
|